Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model

E Cowan, MR Khan, S Shastry, EJ Edelman - Addiction science & clinical …, 2021 - Springer
The COVID-19 pandemic has resulted in unparalleled societal disruption with wide ranging
effects on individual liberties, the economy, and physical and mental health. While no social …

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment

CL Masson, KL Delucchi… - … journal of public …, 2013 - ajph.aphapublications.org
Objectives. We evaluated the efficacy of a hepatitis care coordination intervention to improve
linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical …

[HTML][HTML] HCV elimination in a Swiss opioid agonist therapy programme–a cohort study

A Bregenzer, C Krismer, S Wendel, P Roser… - Swiss Medical …, 2022 - smw.ch
BACKGROUND: In opioid agonist therapy (OAT) programmes, chronic hepatitis C is highly
prevalent and directly observed therapy guarantees optimal adherence. Since 2017, all …

HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil

EF da Silva, DF Mazo, CP Oliveira… - Annals of …, 2017 - medigraphic.com
Background. Patients with chronic HCV infection and superinfection by hepatitis A virus
(HAV) or hepatitis B virus (HBV) have higher morbidity and mortality when compared with …

Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions

DC Perlman, AE Jordan, C McKnight… - Journal of addictive …, 2014 - Taylor & Francis
Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A,
Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug …

low prevalence of vaccination or documented immunity to hepatitis A and hepatitis B viruses among individuals with chronic liver disease

RJ Wong, RG Gish, R Cheung, AS Chitnis - The American Journal of …, 2021 - Elsevier
Background Despite national guidelines emphasizing the importance of vaccination or
documenting immunity to hepatitis A virus and hepatitis B virus for patients with chronic liver …

Variation in the viral hepatitis and HIV policies and practices of methadone maintenance programs

AB Jessop, JK Hom, M Burke - Journal of Addiction Medicine, 2017 - journals.lww.com
Objective: Patients prescribed methadone maintenance treatment (MMT) demonstrate
elevated prevalence of hepatitis B virus (HBV), hepatitis C virus, and HIV. Government …

[HTML][HTML] HCV elimination in a Swiss opioid agonist therapy programme–a cohort and sequential cross-sectional study

A Bregenzer, C Krismer, S Wendel, P Roser, CA Fux - smw.ch
BACKGROUND: In opioid agonist therapy (OAT) programmes, chronic hepatitis C is highly
prevalent and directly observed therapy guarantees optimal adherence. Since 2017, all …

[PDF][PDF] Co-Infection of HBV in Partially/Non-Vaccinated Diagnosed HCV Positive Patients

RM Khan, A Khan - Medical Forum Monthly, 2019 - academia.edu
Objective: To determine the frequency of co-infection of HBV in partially/non-vaccinated
diagnosed HCV positive patients. Study Design: Descriptive/cross-sectional study. Place …

[PDF][PDF] Frequency of Hepatitis “B” Vaccination in Already Diagnosed “HCV” Positive Patients

RM Khan, A Khan, S ul Haq, A Shah - Medical Forum Monthly, 2019 - medforum.pk
Objective: To determine the frequency of Hepatitis “B” vaccination in already diagnosed
“HCV” positive patients Study Design: Descriptive, cross-sectional. Place and Duration of …